Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Jan 15, 2022; 14(1): 265-277
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.265
Figure 2
Figure 2 The linear analysis of E-cadherin protein expression in normal gastric cardia mucosa, dysplasia and gastric cardia adenocarcinoma. With the lesions progressed from normal gastric cardia mucosa to dysplasia and gastric cardia adenocarcinoma, the positive immunostaining rates for E-cadherin decreased significantly from 100% to 93.0% and 84.1%, respectively (y = - 0.08x + 1.0833, R2 = 0.9948).